Amend SB 1143 (House Committee Report) as follows: (1) On page 3, between line 18 and line 19, insert new SECTION 3, as follows: SECTION 3. Chapter 32, Insurance Code, is amended by adding new Section 32.0221, to read as follows: Sec. 32.0221. TEXAS HEALTH BENEFITS STUDY. (a) The department shall study the disparity in patient co-payments between orally- and intravenously-administered chemotherapies, the reasons for the disparity, and the patient benefits in establishing co-payment parity between oral and infused chemotherapy agents. (b) Not later than August 1, 2010, the department shall submit to the governor, the lieutenant governor, the speaker of the house of representatives, and the appropriate standing committees of the legislature a report regarding the results of the study conducted under Subsection (a), together with any recommendation for legislation. (2) On page 3, line 19, between "by" and "this", insert "SECTION 1 and SECTION 2 of". (3) Renumber the remaining sections of the bill as appropriate.